Analysts expect GSK plc to report revenue of 12.17 B for Q4 26, against a range of 11.63 B to 12.71 B. The most recent reported quarter, Q3 26, came in at 11.94 B, a 2.2% miss against the 12.20 B consensus.
| Metric | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 11.07 B | 10.85 B | 10.61 B | 10.13 B | 10.54 B | 11.06 B | 9.83 B | 10.20 B | 10.42 B | 10.16 B | 10.04 B | 10.61 B | 11.32 B | 11.78 B | 10.30 B | 11.18 B | 11.94 B | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 12.52 B | 13.14 B | 11.03 B | 11.13 B | 11.69 B | 10.99 B | 10.35 B | 11.45 B | 11.11 B | 10.66 B | 10.86 B | 12.15 B | 10.82 B | 11.55 B | 10.92 B | 12.10 B | 12.74 B | 12.71 B | 11.31 B | 13.31 B | 13.84 B | 13.88 B | 11.79 B | 13.33 B | 13.47 B | |||||||||
| Low Estimate | 11.01 B | 11.17 B | 9.31 B | 9.15 B | 10.18 B | 9.40 B | 8.98 B | 9.73 B | 10.39 B | 9.04 B | 9.90 B | 9.95 B | 10.07 B | 10.48 B | 9.00 B | 10.70 B | 11.67 B | 11.63 B | 9.27 B | 11.54 B | 11.80 B | 12.45 B | 9.65 B | 11.67 B | 12.51 B | |||||||||
| Consensus Estimate | 11.77 B | 12.16 B | 10.17 B | 10.14 B | 10.94 B | 10.20 B | 9.67 B | 10.59 B | 10.75 B | 9.85 B | 10.38 B | 11.05 B | 10.45 B | 11.01 B | 9.96 B | 11.40 B | 12.20 B | 12.17 B | 10.29 B | 12.42 B | 12.82 B | 13.17 B | 10.72 B | 12.50 B | 12.99 B |
Analysts expect GSK plc to report earnings per share of 0.76 for Q4 26, against a range of 0.71 to 0.81. The most recent reported quarter, Q3 26, came in at 1.02, a 17.5% miss against the 1.24 consensus.
| Metric | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.95 | 0.87 | 0.87 | 0.83 | 0.86 | 1.04 | 0.82 | 0.85 | 1.29 | 0.58 | 1.20 | 1.24 | 1.46 | 0.70 | 1.26 | 1.34 | 1.02 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 1.03 | 0.96 | 0.93 | 0.85 | 0.91 | 0.96 | 0.84 | 0.93 | 1.13 | 0.51 | 1.01 | 1.36 | 1.26 | 0.63 | 1.16 | 1.29 | 1.34 | 0.81 | 1.47 | 1.55 | 1.60 | 0.85 | 1.50 | 1.51 | 1.86 | |||||||||
| Low Estimate | 0.93 | 0.82 | 0.87 | 0.75 | 0.83 | 0.82 | 0.76 | 0.81 | 1.03 | 0.43 | 0.93 | 1.12 | 1.12 | 0.59 | 0.98 | 1.13 | 1.14 | 0.71 | 1.35 | 1.29 | 1.40 | 0.71 | 1.24 | 1.25 | 1.62 | |||||||||
| Consensus Estimate | 0.98 | 0.89 | 0.90 | 0.80 | 0.87 | 0.89 | 0.80 | 0.87 | 1.08 | 0.47 | 0.97 | 1.24 | 1.19 | 0.61 | 1.07 | 1.21 | 1.24 | 0.76 | 1.41 | 1.42 | 1.50 | 0.78 | 1.37 | 1.38 | 1.74 |
Pull Wall Street consensus for GSK plc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=GSK&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "GSK", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=GSK&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();